世界卫生组织《应用新一代靶向测序技术检测耐药结核病:快速通告,2023》解读  

Interpretation of the World Health Organization’s Use of targeted next-generation sequencing to detect drug-resistant tuberculosis Rapid communication,2023

作　　者：黄海荣 Huang Hairong(National Clinical Laboratory on Tuberculosis,Beijing Chest Hospital,Capital Medical University,Beijing 101149,China)

机构地区：[1]首都医科大学附属北京胸科医院国家结核病临床实验室,北京101149

出　　处：《中国防痨杂志》2023年第10期921-924,共4页Chinese Journal of Antituberculosis

基　　金：北京市卫生健康委员会高层次公共卫生人才项目(G2023-2-002)。

摘　　要：世界卫生组织近期发布了《应用新一代靶向测序技术检测耐药结核病:快速通告,2023》,目的是向全球及时分享关于新一代靶向测序技术在耐药结核病应用情况的重要数据,以及据此形成的主要观点,从而推动该技术的合理应用和推广。本文对该通告中的重要数据和观点进行了解读,以便读者了解新一代靶向测序技术对耐药结核病诊断的价值。The World Health Organization released“Use of targeted next-generation sequencing to detect drug-resistant tuberculosis Rapid communication,2023”recently,in order to timely share the important data and opinions formed accordingly on drug resistance detection by the targeted next-generation sequencing technique.Therefore,facilitate the understanding of this new technique and accelerate its promotion.This note interpreted the key data and the opinions in the rapid communication,so as to help the reader to recognize the value of the targeted next-generation sequencing technique in the diagnosis of drug resistant tuberculosis.

关 键 词：分枝杆菌 结核 抗药性 细菌 诊断技术和方法 基因 细菌 总结性报告(主题) 

分 类 号：R52[医药卫生—内科学] R825.2[医药卫生—临床医学]